Recent trends and future directions for the medical treatment of ulcerative colitis.

@article{Naganuma2016RecentTA,
  title={Recent trends and future directions for the medical treatment of ulcerative colitis.},
  author={Makoto Naganuma and Shinta Mizuno and Kosaku Nanki and Shinya Sugimoto and T. Hosokawa Kanai},
  journal={Clinical journal of gastroenterology},
  year={2016},
  volume={9 6},
  pages={329-336}
}
Recently, several medical treatments for ulcerative colitis (UC) have been developed, including 5-aminosalicylic acids (5-ASAs), corticosteroids, thiopurine, calcineurin inhibitors, and anti-tumor necrosis factor (TNF) α treatments. Treatment options including calcineurin inhibitors and anti-TNF treatment for refractory UC are discussed in this article. Furthermore, upcoming treatments are introduced, such as golimumab, vedolizumab, AJM300, tofacitinib. Budesonide foamwill be used as one… CONTINUE READING